Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
about
Improving power of association tests using multiple sets of imputed genotypes from distributed reference panels.Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience.
P2860
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@en
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@nl
type
label
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@en
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@nl
prefLabel
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@en
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@nl
P2093
P2860
P356
P1433
P1476
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
@en
P2093
Gaoxiang Ma
Haiyan Chu
Meilin Wang
Yunyan Wang
Zhengdong Zhang
P2860
P2888
P356
10.1038/SREP33542
P407
P577
2016-09-16T00:00:00Z